Jung-Min Ahn

Featured in: Favicon

oxfordjournals.org Favicon

thelancet.com Favicon

ahajournals.org Favicon

onlinejacc.org Favicon

ajconline.org Favicon

internationaljournalofcardiology.com Favicon

heart.bmj.com Favicon

ehjcimaging.oxfordjournals.org Favicon

interventions.onlinejacc.org

Articles

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial

Apr 8, 2024 | thelancet.com | Seung-Jung Park |Jung-Min Ahn |Do-Yoon Kang

Summary Acute coronary syndrome and sudden cardiac death are often caused by rupture and thrombosis of lipid-rich atherosclerotic coronary plaques (known as vulnerable plaques), many of which are non-flow-limiting. The safety and effectiveness of focal preventive therapy with percutaneous coronary intervention of vulnerable plaques in reducing adverse cardiac events are unknown.
Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease:

Jan 8, 2024 | jacc.org | Do-Yoon Kang |Jung-Min Ahn |Min Joo Kim |Pil Hyung Lee

References1. "2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". J Am Coll Cardiol . 2022;79:2: e21-e129. 2. "2018 ESC/EACTS guidelines on myocardial revascularization". Eur Heart J . 2019;40:87-165. 3.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →